+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bronchopulmonary Dysplasia - Epidemiology Forecast to 2030

  • ID: 5292775
  • Report
  • February 2021
  • Region: Global
  • 225 pages
  • DelveInsight
1 of 2
This ‘Bronchopulmonary Dysplasia (BPD) - Epidemiology Forecast - 2030’ report delivers an in-depth understanding of the BPD, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.

BPD Disease Understanding

Bronchopulmonary Dysplasia (BPD) also known as Chronic Lung Disease of infancy is a serious lung condition that affects newborns. BPD mostly affects premature newborns who need oxygen therapy, which is oxygen given through nasal prongs, a mask, or a breathing tube.

If premature newborns still require oxygen therapy by the time, they reach 36 weeks gestation, they are diagnosed with BPD. BPD develops as a result of a newborn's lungs not developing normally while the baby is growing in the womb or not developing fully if the baby was born prematurely. These babies’ lungs are fragile and can be easily irritated or inflamed after birth. Most newborns who develop BPD are born more than 10 weeks before their due dates, weigh less than 2 pounds at birth, and have breathing problems. Infections that occur before or shortly after birth also can contribute to BPD.

The first sign of BPD is when premature newborns - usually those born more than 10 weeks early - still need oxygen therapy by the time they reach 36 weeks gestation. Newborns who have severe BPD may have trouble feeding, which can lead to delayed growth. These babies also may develop pulmonary hypertension and Cor pulmonale, which is the failure of the right side of the heart.

BPD can be mild, moderate, or severe. The diagnosis depends on how much extra oxygen a baby needs at the time of the original due date. It also depends on how long the baby needs oxygen therapy.

BPD Epidemiology

The BPD epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The total incident cases of BPD patients are increasing in the geographies during the study period, i.e., 2017-2030.

The disease epidemiology covered in the report provides historical as well as forecasted BPD symptoms epidemiology segmented as the Total Preterm Births, Total Preterm Births Based on Gestation Week, Total cases of BPD, Total incident cases of BPD based on Gestation Period, Total incident cases of BPD based on Birth Weight, and Severity of specific cases of BPD. The report includes the incident scenario of BPD symptoms in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden from 2017 to 2030.

Country-wise - BPD Epidemiology

The epidemiology segment also provides the BPD epidemiology data and findings across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.

The total number of incident cases of BPD was 165,274 in 2020.
  • As per the estimates, India has the largest incident population of BPD.
  • Among the EU5 countries, Germany had the highest incident cases of BPD, followed by the UK. On the other hand, Spain had the lowest incident cases, with 859 cases in 2020 in EU5.
Scope of the Report
  • The BPD report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
  • The BPD Epidemiology Report and Model provide an overview of the risk factors and global trends of BPD in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
  • The report provides insight into the historical and forecasted patient pool of BPD in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
  • The report helps to recognize the growth opportunities concerning the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of BPD.
  • The report provides the segmentation of the BPD epidemiology by total preterm births in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
  • The report provides the segmentation of the BPD epidemiology by total preterm births based on gestation week in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
  • The report provides the segmentation of the BPD epidemiology by total cases of BPD in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
  • The report provides the segmentation of the BPD epidemiology by total incident cases of BPD based on gestation period in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
  • The report provides the segmentation of the BPD epidemiology by total incident cases of BPD based on birth weight in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
  • The report provides the segmentation of the BPD epidemiology by the severity of specific cases of BPD in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden.
Report Highlights
  • 11-year Forecast of BPD epidemiology
  • The United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), Japan, Algeria, Australia, Canada, China, Egypt, India, Kenya, Nigeria, Norway, Netherland, South Korea, and Sweden Coverage
  • Incident Cases according to segmentation: Total Preterm Births
  • Incident Cases according to segmentation: Total Preterm Births Based on Gestation Week
  • Incident Cases according to segmentation: Total cases of BPD
  • Incident Cases according to segmentation: Total incident cases of BPD based on Gestation Period
  • Incident Cases according to segmentation: Total incident cases of BPD based on Birth Weight
  • Incident Cases according to segmentation: Severity of specific cases of BPD
KOL Views

We interview KOLs, and SME's opinion through primary research to fill the data gaps and validate the secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered
  • What will be the growth opportunities for the patient population of BPD?
  • What are the key findings of the BPD epidemiology across the different geographies and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients with BPD across the different geographies during the forecast period (2017-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow during the forecast period (2017-2030)?
  • What are the disease risk, burdens, and unmet needs of the BPD?
  • What are the currently available treatments for BPD?
Reasons to Buy

The BPD epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global BPD market
  • Quantify patient populations in the global BPD market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for BPD therapeutics in each of the markets covered
  • Understand the magnitude of the total preterm births.
  • Understand the magnitude of the total preterm births based on gestation week.
  • Understand the magnitude of the total cases of BPD.
  • Understand the magnitude of the total incident cases of BPD based on gestation period.
  • Understand the magnitude of the total incident cases of BPD based on birth weight.
  • Understand the magnitude of the severity of specific cases of BPD.
  • The BPD epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
  • The BPD Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over an 11-year forecast period using reputable sources
Key Assessments
  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population
Geographies Covered
  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan
  • Algeria
  • Australia
  • Canada
  • China
  • Egypt
  • India
  • Kenya
  • Nigeria
  • Norway
  • Netherland
  • South Korea
  • Sweden
Study Period:
2017-2030

The study conducted by Csaba Siffel et al. (n.d.) titled “Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review” evaluated the global incidence of BPD among infants born extremely preterm. In this study, a systematic review of the literature was conducted in Embase and MEDLINE (via PubMed) using a pre-specified search strategy for BPD and prematurity. Among which observational studies published in English between 16 May 2006 and 16 October 2017 reporting on the occurrence of BPD in infants born< 28 weeks GA were included. Literature searches yielded the reported global incidence range of BPD which was 10-89% (10-73% in Europe, 18-89% in North America, 18-82% in Asia, and30-62% in Oceania).

Richard AE et al. (n.d.) had conducted a study titled “Validation of the National Institutes of Health Consensus Definition of bronchopulmonary Dysplasia” for the predictive validity of the severity-based, consensus definition of BPD as per the National Institute of Child Health and Human Development (NICHD)/National Heart, Lung, and Blood Institute Workshop (June 2000). This specific workshop had proposed a severity-based definition of BPD for infants 28 days but not at 36 weeks’ postmenstrual age (PMA) or discharge, severe BPD as O2 for ≥28 days plus ≥30% O2 and/or positive pressure at 36 weeks’ PMA. The data from 4866 infants (birth weight < 1000g, GA < 32 weeks, alive at 36 weeks’ PMA) who were entered into the NICHD VLBW Infant Registry and Follow-up data of 3848 were compared among infants with the consensus definition of BPD.
Note: Product cover images may vary from those shown
2 of 2
1 Key Insights

2 Executive Summary of BPD

3 Disease Background and Overview
3.1 Introduction
3.2 Incidence of Bronchopulmonary Dysplasia (BPD)
3.3 Signs and Symptoms
3.4 Risk factors
3.5 Pathophysiology
3.6 Biomarkers of BPD
3.7 Diagnosis
3.7.1 Criteria for diagnosis of BPD

4 Epidemiology and Patient Population
4.1 Key Findings
4.2 Assumptions and Rationale

5 Bronchopulmonary Dysplasia Epidemiology
5.1 Total Incident Cases of Bronchopulmonary Dysplasia
5.2 The United States
5.2.1 Total Preterm Births in the United States
5.2.2 Total Preterm Births Based on Gestation Week in the United States
5.2.3 Total cases of Bronchopulmonary Dysplasia (BPD) in the United States
5.2.4 Total incident cases of BPD based on Gestation Period in the United States
5.2.5 Total incident cases of BPD based on Birth Weight in the United States
5.2.6 Severity of specific cases of BPD in the United States
5.3 Germany
5.3.1 Total Preterm births in Germany
5.3.2 Total Preterm Births based on Gestation Week in Germany
5.3.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Germany
5.3.4 Total incident cases of BPD based on Gestation Period in Germany
5.3.5 Total incident cases of BPD based on Birth Weight in Germany
5.3.6 Severity of specific cases of BPD in Germany
5.4 France
5.4.1 Total Preterm births in France
5.4.2 Total Preterm births based on Gestation weeks in France
5.4.3 Total cases of Bronchopulmonary Dysplasia (BPD) in France
5.4.4 Total incident cases of BPD based on Gestation Period in France
5.4.5 Total incident cases of BPD based on Birth Weight in France
5.4.6 Severity of specific cases of BPD in France
5.5 Italy
5.5.1 Total Preterm births in Italy
5.5.2 Total Preterm births based on Gestation Weeks in Italy
5.5.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Italy
5.5.4 Total incident cases of BPD based on Gestation Period in Italy
5.5.5 Total incident cases of BPD based on Birth Weight in Italy
5.5.6 Severity of specific cases of BPD in Italy
5.6 Spain
5.6.1 Total Preterm births in Spain
5.6.2 Total Preterm births Based on Gestation period in Spain
5.6.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Spain
5.6.4 Total incident cases of BPD based on Gestation Period in Spain
5.6.5 Total incident cases of BPD based on Birth Weight in Spain
5.6.6 Severity of specific cases of BPD in Spain
5.7 United Kingdom
5.7.1 Total Preterm births in the United Kingdom
5.7.2 Total Preterm births based on Gestation weeks in United Kingdom
5.7.3 Total cases of Bronchopulmonary Dysplasia (BPD) in the United Kingdom
5.7.4 Total incident cases of BPD based on Gestation Period in the United Kingdom
5.7.5 Total incident cases of BPD based on Birth Weight in the United Kingdom
5.7.6 Severity of specific cases of BPD in the United Kingdom
5.8 Japan
5.8.1 Total Preterm births in Japan
5.8.2 Total Preterm births based on Gestation weeks in Japan
5.8.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Japan
5.8.4 Total incident cases of BPD based on Gestation Period in Japan
5.8.5 Total incident cases of BPD based on Birth Weight in Japan
5.8.6 Severity of specific cases of BPD in Japan
5.9 Algeria
5.9.1 Total Preterm births in Algeria
5.9.2 Total Preterm births Based on Gestation weeks in Algeria
5.9.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Algeria
5.9.4 Total incident cases of BPD based on Gestation Period in Algeria
5.9.5 Total incident cases of BPD based on Birth Weight in Algeria
5.9.6 Severity of specific cases of BPD in Algeria
5.1 Australia
5.10.1 Total Preterm births in Australia
5.10.2 Total Preterm births Based on Gestation Weeks in Australia
5.10.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Australia
5.10.4 Total incident cases of BPD based on Gestation Period in Australia
5.10.5 Total incident cases of BPD based on Birth Weight in Australia
5.10.6 Severity of specific cases of BPD in Australia
5.11 Canada
5.11.1 Total Preterm births in Canada
5.11.2 Total Preterm births Based on Gestation Weeks in Canada
5.11.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Canada
5.11.4 Total incident cases of BPD based on Gestation Period in Canada
5.11.5 Total incident cases of BPD based on Birth Weight in Canada
5.11.6 Severity of specific cases of BPD in Canada
5.12 China
5.12.1 Total Preterm births in China
5.12.2 Total Preterm births Based on Gestation Weeks in China
5.12.3 Total cases of Bronchopulmonary Dysplasia (BPD) in China
5.12.4 Total incident cases of BPD based on Gestation Period in China
5.12.5 Total incident cases of BPD based on Birth Weight in China
5.12.6 Severity of specific cases of BPD in China
5.13 Egypt
5.13.1 Total Preterm births in Egypt
5.13.2 Total Preterm births Based on Gestation Week in Egypt
5.13.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Egypt
5.13.4 Total incident cases of BPD based on Gestation Period in Egypt
5.13.5 Total incident cases of BPD based on Birth Weight in Egypt
5.13.6 Severity of specific cases of BPD in Egypt
5.14 India
5.14.1 Total Preterm births in India
5.14.2 Total Preterm births Based on Gestation Weeks in India
5.14.3 Total cases of Bronchopulmonary Dysplasia (BPD) in India
5.14.4 Total incident cases of BPD based on Gestation Period in India
5.14.5 Total incident cases of BPD based on Birth Weight in India
5.14.6 Severity of specific cases of BPD in India
5.15 Kenya
5.15.1 Total Preterm births in Kenya
5.15.2 Total Preterm births Based on Gestation Weeks in Kenya
5.15.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Kenya
5.15.4 Total incident cases of BPD based on Gestation Period in Kenya
5.15.5 Total incident cases of BPD based on Birth Weight in Kenya
5.15.6 Severity of specific cases of BPD in Kenya
5.16 Nigeria
5.16.1 Total Preterm births in Nigeria
5.16.2 Total Preterm births Based on Gestation Weeks in Nigeria
5.16.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Nigeria
5.16.4 Total incident cases of BPD based on Gestation Period in Nigeria
5.16.5 Total incident cases of BPD based on Birth Weight in Nigeria
5.16.6 Severity of specific cases of BPD in Nigeria
5.17 Norway
5.17.1 Total Preterm births in Norway
5.17.2 Total Preterm births Based on Gestation Weeks in Norway
5.17.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Norway
5.17.4 Total incident cases of BPD based on Gestation Period in Norway
5.17.5 Total incident cases of BPD based on Birth Weight in Norway
5.17.6 Severity of specific cases of BPD in Norway
5.18 Netherland
5.18.1 Total Preterm births in Netherland
5.18.2 Total Preterm births Based on Gestation weeks in Netherland
5.18.3 Total cases of Bronchopulmonary Dysplasia (BPD) in the Netherland
5.18.4 Total incident cases of BPD based on Gestation Period in Netherland
5.18.5 Total incident cases of BPD based on Birth Weight in the Netherland
5.18.6 Severity of specific cases of BPD in Netherland
5.19 South Korea
5.19.1 Total Preterm births in South Korea
5.19.2 Total Preterm births Based on Gestation weeks in South Korea
5.19.3 Total cases of Bronchopulmonary Dysplasia (BPD) in South Korea
5.19.4 Total incident cases of BPD based on Gestation Period in South Korea
5.19.5 Total incident cases of BPD based on Birth Weight in South Korea
5.19.6 Severity of specific cases of BPD in South Korea
5.2 Sweden
5.20.1 Total Preterm births in Sweden
5.20.2 Total Preterm births in Sweden
5.20.3 Total cases of Bronchopulmonary Dysplasia (BPD) in Sweden
5.20.4 Total incident cases of BPD based on Gestation Period in Sweden
5.20.5 Total incident cases of BPD based on Birth Weight in Sweden
5.20.6 Severity of specific cases of BPD in Sweden

6 Treatment and Management
6.1 Treatment and Management of Bronchopulmonary Dysplasia
6.2 Bronchopulmonary Dysplasia: Evidence-Based Pharmacologic Therapies
6.3 Management of Bronchopulmonary Dysplasia - US Preventive Services Task Force
6.4 Guidelines for the use of postnatal corticosteroids in preterm neonates have been endorsed by pediatric associations in North America and Europe
6.5 Respiratory management of infants with chronic neonatal lung disease beyond the NICU: A position statement from the Thoracic Society of Australia

7 Key Cross Competition

8 Drug Pricing Assumption: Emerging and Current Therapies

9 Unmet Needs

10 Organizations contributing toward BPD

11 Case studies
11.1 Lung Transplantation for Bronchopulmonary Dysplasia in Adults: A Case Report
11.2 Two Cases of Bronchopulmonary Dysplasia of Similar Appearance in Adult Monozygotic Twin: Pathology and Computed Tomographic Findings
11.3 Bronchopulmonary Dysplasia: A Case Report
11.4 Severe bronchopulmonary dysplasia improved by noninvasive positive pressure ventilation: A Case Report
11.5 Bronchopulmonary Dysplasia in a Premature Infant: A Case Report

12 KOL Views

13 Patient Journey

14 Market Drivers

15 Market Barriers

16 SWOT Analysis for BPD

17 Appendix
17.1 Report Methodology
17.2 References

18 Publisher Capabilities

19 Disclaimer

20 About the Publisher

List of Tables
Table 1: Summary of Bronchopulmonary Dysplasia Epidemiology, and Key Events (2017-2030)
Table 2: Evolution of pathology in BPD
Table 3: Gene associated with BPD
Table 4: Definition of Bronchopulmonary Dysplasia: Diagnostic Criteria
Table 5: Total Incident Cases of Bronchopulmonary Dysplasia (2017-2030)
Table 6: Total Preterm births in the United States (2017-2030)
Table 7: Total Preterm Births Based on Gestation Week in the United States (2017-2030)
Table 8: Total cases of Bronchopulmonary Dysplasia in the US (2017-2030)
Table 9: Total incident cases of BPD based on Gestation Period in the US (2017-2030)
Table 10: Total incident cases of BPD based on Birth Weight in the US (2017-2030)
Table 11: Severity of specific cases of BPDSeverity of specific cases of BPD in the US (2017-2030)
Table 12: Total Preterm births in Germany (2017-2030)
Table 13: Total Preterm Births Based on Gestation Week in Germany (2017-2030)
Table 14: Total cases of Bronchopulmonary Dysplasia (BPD) in Germany (2017-2030)
Table 15: Total incident cases of BPD based on Gestation Period in Germany (2017-2030)
Table 16: Total incident cases of BPD based on Birth Weight in Germany (2017-2030)
Table 17: Severity of specific cases of BPD in Germany (2017-2030)
Table 18: Total Preterm births in France (2017-2030)
Table 19: Total Preterm births Based on Gestation Weeks in France (2017-2030)
Table 20: Total cases of Bronchopulmonary Dysplasia (BPD) in France (2017-2030)
Table 21: Total incident cases of BPD based on Gestation Period in France (2017-2030)
Table 22: Total incident cases of BPD based on Birth Weight in France (2017-2030)
Table 23: Severity of specific cases of BPD in France (2017-2030)
Table 24: Total Preterm births in Italy (2017-2030)
Table 25: Total Preterm births based on Gestation weeks in Italy (2017-2030)
Table 26: Total Cases of Bronchopulmonary Dysplasia in Italy (2017-2030)
Table 27: Total incident cases of BPD based on Gestation Period in Italy (2017-2030)
Table 28: Total incident cases of BPD based on Birth Weight in Italy (2017-2030)
Table 29: Severity of specific cases of BPD in Italy (2017-2030)
Table 30: Total Preterm births in Spain (2017-2030)
Table 31: Total Preterm births based on Gestation Weeks in Spain (2017-2030)
Table 32: Total cases of Bronchopulmonary Dysplasia (BPD) in Spain (2017-2030)
Table 33: Total incident cases of BPD based on Gestation Period in Spain (2017-2030)
Table 34: Total incident cases of BPD based on Birth Weight in Spain (2017-2030)
Table 35: Severity of specific cases of BPD in Spain (2017-2030)
Table 36: Total Preterm births in the United Kingdom (2017-2030)
Table 37: Total Preterm births in the United Kingdom (2017-2030)
Table 38: Total cases of Bronchopulmonary Dysplasia (BPD) in the UK (2017-2030)
Table 39: Total incident cases of BPD based on Gestation Period in the UK (2017-2030)
Table 40: Total incident cases of BPD based on Birth Weight in the UK (2017-2030)
Table 41: Severity of specific cases of BPD in the UK (2017-2030)
Table 42: Total Preterm birth in Japan (2017-2030)
Table 43: Total Preterm birth based on Gestation Weeks in Japan (2017-2030)
Table 44: Total cases of Bronchopulmonary Dysplasia (BPD) in Japan (2017-2030)
Table 45: Total incident cases of BPD based on Gestation Period in Japan (2017-2030)
Table 46: Total incident cases of BPD based on Birth Weight in Japan (2017-2030)
Table 47: Severity of specific cases of BPD in Japan (2017-2030)
Table 48: Total Preterm birth in Algeria (2017-2030)
Table 49: Total Preterm birth Based on Gestation Week in Algeria (2017-2030)
Table 50: Total cases of Bronchopulmonary Dysplasia (BPD) in Algeria (2017-2030)
Table 51: Total incident cases of BPD based on Gestation Period in Algeria (2017-2030)
Table 52: Total incident cases of BPD based on Birth Weight in Algeria (2017-2030)
Table 53: Severity of specific cases of BPD in Algeria (2017-2030)
Table 54: Total Preterm births in Australia (2017-2030)
Table 55: Total Preterm births Based on Gestation week in Australia (2017-2030)
Table 56: Total cases of Bronchopulmonary Dysplasia (BPD) in Australia (2017-2030)
Table 57: Total incident cases of BPD based on Gestation Period in Australia (2017-2030)
Table 58: Total incident cases of BPD based on Birth Weight in Australia (2017-2030)
Table 59: Severity of specific cases of BPD in Australia (2017-2030)
Table 60: Total Preterm birth in Canada (2017-2030)
Table 61: Total Preterm birth Based On Gestation weeks in Canada (2017-2030)
Table 62: Total cases of Bronchopulmonary Dysplasia (BPD) in Canada (2017-2030)
Table 63: Total incident cases of BPD based on Gestation Period in Canada(2017-2030)
Table 64: Total incident cases of BPD based on Birth Weight in Canada (2017-2030)
Table 65: Severity of specific cases of BPD in Canada(2017-2030)
Table 66: Total Preterm birth in China(2017-2030)
Table 67: Total Preterm birth Based On Gestation in China(2017-2030)
Table 68: Total cases of Bronchopulmonary Dysplasia (BPD) in China(2017-2030)
Table 69: Total incident cases of BPD based on Gestation Period in China(2017-2030)
Table 70: Total incident cases of BPD based on Birth Weight in China (2017-2030)
Table 71: Severity of specific cases of BPD in China (2017-2030)
Table 72: Total Preterm birth in Egypt (2017-2030)
Table 73: Total Preterm birth Based On Gestation Week in Egypt (2017-2030)
Table 74: Total cases of Bronchopulmonary Dysplasia (BPD) in Egypt (2017-2030)
Table 75: Total incident cases of BPD based on Gestation Period in Egypt (2017-2030)
Table 76: Total incident cases of BPD based on Birth Weight in Egypt (2017-2030)
Table 77: Severity of specific cases of BPD in Egypt (2017-2030)
Table 78: Total Preterm Births in India (2017-2030)
Table 79: Total Preterm Birth based on Gestation Weeks in India (2017-2030)
Table 80: Total cases of Bronchopulmonary Dysplasia (BPD) in India (2017-2030)
Table 81: Total incident cases of BPD based on Gestation Period in India (2017-2030)
Table 82: Total incident cases of BPD based on Birth Weight in India (2017-2030)
Table 83: Severity of specific cases of BPD in India (2017-2030)
Table 84: Total Preterm birth in Kenya (2017-2030)
Table 85: Total Preterm birth Based on Gestation Weeks in Kenya (2017-2030)
Table 86: Total cases of Bronchopulmonary Dysplasia (BPD) in Kenya (2017-2030)
Table 87: Total incident cases of BPD based on Gestation Period in Kenya (2017-2030)
Table 88: Total incident cases of BPD based on Birth Weight in Kenya (2017-2030)
Table 89: Severity of specific cases of BPD in Kenya (2017-2030)
Table 90: Total Preterm birth in Nigeria (2017-2030)
Table 91: Total Preterm birth Based on Gestation Weeks in Nigeria (2017-2030)
Table 92: Total cases of Bronchopulmonary Dysplasia (BPD) in Nigeria (2017-2030)
Table 93: Total incident cases of BPD based on Gestation Period in Nigeria (2017-2030)
Table 94: Total incident cases of BPD based on Birth Weight in Nigeria (2017-2030)
Table 95: Severity of specific cases of BPD in Nigeria (2017-2030)
Table 96: Total Preterm birth in Norway(2017-2030)
Table 97: Total Preterm birth Based On Gestation Weeks in Norway(2017-2030)
Table 98: Total cases of Bronchopulmonary Dysplasia (BPD) in Norway(2017-2030)
Table 99: Total incident cases of BPD based on Gestation Period in Norway(2017-2030)
Table 100: Total incident cases of BPD based on Birth Weight in Norway (2017-2030)
Table 101: Severity of specific cases of BPD in Norway (2017-2030)
Table 102: Total Preterm birth in Netherland(2017-2030)
Table 103: Total Preterm birth in Netherland(2017-2030)
Table 104: Total cases of Bronchopulmonary Dysplasia (BPD) in the Netherland(2017-2030)
Table 105: Total incident cases of BPD based on Gestation Period in Netherland(2017-2030)
Table 106: Total incident cases of BPD based on Birth Weight in the Netherland (2017-2030)
Table 107: Severity of specific cases of BPD in the Netherland (2017-2030)
Table 108: Total Preterm Birth in South Korea (2017-2030)
Table 109: Total Preterm Birth Based on in South Korea (2017-2030)
Table 110: Total cases of Bronchopulmonary Dysplasia (BPD) in South Korea (2017-2030)
Table 111: Total incident cases of BPD based on Gestation Period in South Korea (2017-2030)
Table 112: Total incident cases of BPD based on Birth Weight in South Korea (2017-2030)
Table 113: Severity of specific cases of BPD in South Korea (2017-2030)
Table 114: Total Preterm birth in Sweden (2017-2030)
Table 115: Total Preterm birth in Sweden (2017-2030)
Table 116: Total cases of Bronchopulmonary Dysplasia (BPD) in Sweden (2017-2030)
Table 117: Total incident cases of BPD based on Gestation Period in Sweden (2017-2030)
Table 118: Total incident cases of BPD based on Birth Weight in Sweden (2017-2030)
Table 119: Severity of specific cases of BPD in Sweden (2017-2030)
Table 120: Factors that may decrease or increase the GRADE quality of evidence
Table 121: Summary of the overall level of evidence and recommendations for therapies to prevent BPD in infants born less than 32 weeks’ gestation
Table 122: Levels of evidence and recommendations for clinical use based on the guidelines developed by the US preventive services task force
Table 123: Management of BPD According to Phase (Early, Evolving, and Established)
Table 124: Recommendations for BPD management by Australasian Pediatric Respiratory Medical Group (APRMG)
Table 125: Key Cross of emerging Therapies

List of Figures
Figure 1: Signs and Symptoms of BPD
Figure 2: Risk Factors of Bronchopulmonary dysplasia
Figure 3: Risk Factor Analysis of BPD
Figure 4: Stages of Lung Development, Potentially Damaging Factors, and Types of Lung Injury
Figure 5: Pathogenesis of BPD: impact of the pulmonary inflammatory response on the premature lung
Figure 6: Total Incident Cases of Bronchopulmonary Dysplasia (2017-2030)
Figure 7: Total Preterm births in the United States (2017-2030)
Figure 8: Total Preterm Births Based on Gestation Week in the United States (2017-2030)
Figure 9: Total cases of Bronchopulmonary Dysplasia by Symptoms in the US (2017-2030)
Figure 10: Total incident cases of BPD based on Gestation Period in the US (2017-2030)
Figure 11: Total incident cases of BPD based on Birth Weight in the US (2017-2030)
Figure 12: Severity of specific cases of BPD in the US (2017-2030)
Figure 13: Total preterm births in Germany (2017-2030)
Figure 14: Total Preterm Births Based on Gestation Week in Germany (2017-2030)
Figure 15: Total cases of Bronchopulmonary Dysplasia (BPD) in Germany (2017-2030)
Figure 16: Total incident cases of BPD based on Gestation Period in Germany (2017-2030)
Figure 17: Total incident cases of BPD based on Birth Weight in Germany (2017-2030)
Figure 18: Severity of specific cases of BPD in Germany (2017-2030)
Figure 19: Total Preterm births in France (2017-2030)
Figure 20: Total Preterm births Based on Gestation Weeks in France (2017-2030)
Figure 21: Total cases of Bronchopulmonary Dysplasia (BPD) in France (2017-2030)
Figure 22: Total incident cases of BPD based on Gestation Period in France (2017-2030)
Figure 23: Total incident cases of BPD based on Birth Weight in France (2017-2030)
Figure 24: Severity of specific cases of BPD in France (2017-2030)
Figure 25: Total Preterm births in Italy (2017-2030)
Figure 26: Total Preterm Births based on Gestation Week's births in Italy (2017-2030)
Figure 27: Total cases of Bronchopulmonary Dysplasia (BPD) in Italy (2017-2030)
Figure 28: Total incident cases of BPD based on Gestation Period in Italy (2017-2030)
Figure 29: Total incident cases of BPD based on Birth Weight in Italy (2017-2030)
Figure 30: Severity of specific cases of BPD in Italy (2017-2030)
Figure 31: Total Preterm births in Spain (2017-2030)
Figure 32: Total Preterm births Based on gestation period in Spain (2017-2030)
Figure 33: Total cases of Bronchopulmonary Dysplasia (BPD) in Spain (2017-2030)
Figure 34: Total incident cases of BPD based on Gestation Period in Spain (2017-2030)
Figure 35: Total incident cases of BPD based on Birth Weight in Spain (2017-2030)
Figure 36: Severity of specific cases of BPD in Spain (2017-2030)
Figure 37: Total Preterm births in the UK (2017-2030)
Figure 38: Total Preterm births based on Gestation weeks in the UK (2017-2030)
Figure 39: Total cases of Bronchopulmonary Dysplasia (BPD) in the UK (2017-2030)
Figure 40: Total incident cases of BPD based on Gestation Period in the UK (2017-2030)
Figure 41: Total incident cases of BPD based on Birth Weight in the UK (2017-2030)
Figure 42: Severity of specific cases of BPD in the UK (2017-2030)
Figure 43: Total Preterm births in Japan (2017-2030)
Figure 44: Total Preterm births based on Gestation Weeks in Japan (2017-2030)
Figure 45: Total cases of Bronchopulmonary Dysplasia (BPD) in Japan (2017-2030)
Figure 46: Total incident cases of BPD based on Gestation Period in Japan (2017-2030)
Figure 47: Total incident cases of BPD based on Birth Weight in Japan (2017-2030)
Figure 48: Severity of specific cases of BPD in Japan (2017-2030)
Figure 49: Total Preterm births in Algeria (2017-2030)
Figure 50: Total Preterm births Based On Gestation Week in Algeria (2017-2030)
Figure 51: Total cases of Bronchopulmonary Dysplasia (BPD) in Algeria (2017-2030)
Figure 52: Total incident cases of BPD based on Gestation Period in Algeria (2017-2030)
Figure 53: Total incident cases of BPD based on Birth Weight in Algeria (2017-2030)
Figure 54: Severity of specific cases of BPD in Algeria (2017-2030)
Figure 55: Total Preterm births in Australia (2017-2030)
Figure 56: Total Preterm births based on Gestation Weeks in Australia (2017-2030)
Figure 57: Total cases of Bronchopulmonary Dysplasia (BPD) in Australia (2017-2030)
Figure 58: Total incident cases of BPD based on Gestation Period in Australia (2017-2030)
Figure 59: Total incident cases of BPD based on Birth Weight in Australia (2017-2030)
Figure 60: Severity of specific cases of BPD in Australia (2017-2030)
Figure 61: Total Preterm births in Canada (2017-2030)
Figure 62: Total Preterm births Based On Gestation Weeks in Canada (2017-2030)
Figure 63: Total cases of Bronchopulmonary Dysplasia (BPD) in Canada (2017-2030)
Figure 64: Total incident cases of BPD based on Gestation Period in Canada (2017-2030)
Figure 65: Total incident cases of BPD based on Birth Weight in Canada (2017-2030)
Figure 66: Severity of specific cases of BPD in Canada (2017-2030)
Figure 67: Total Preterm births in China (2017-2030)
Figure 68: Total Preterm births Based on Gestation Weeks in China (2017-2030)
Figure 69: Total cases of Bronchopulmonary Dysplasia (BPD) in China (2017-2030)
Figure 70: Total incident cases of BPD based on Gestation Period in China (2017-2030)
Figure 71: Total incident cases of BPD based on Birth Weight in China (2017-2030)
Figure 72: Severity of specific cases of BPD in China (2017-2030)
Figure 73: Total Preterm births in Egypt (2017-2030)
Figure 74: Total Preterm births Based on Gestation week in Egypt (2017-2030)
Figure 75: Total cases of Bronchopulmonary Dysplasia (BPD) in Egypt (2017-2030)
Figure 76: Total incident cases of BPD based on Gestation Period in Egypt (2017-2030)
Figure 77: Total incident cases of BPD based on Birth Weight in Egypt (2017-2030)
Figure 78: Severity of specific cases of BPD in Egypt (2017-2030)
Figure 79: Total Preterm births in India (2017-2030)
Figure 80: Total Preterm births Based on Gestation weeks in India (2017-2030)
Figure 81: Total cases of Bronchopulmonary Dysplasia (BPD) in India (2017-2030)
Figure 82: Total incident cases of BPD based on Gestation Period in India (2017-2030)
Figure 83: Total incident cases of BPD based on Birth Weight in India (2017-2030)
Figure 84: Severity of specific cases of BPD in India (2017-2030)
Figure 85: Total Preterm births in Kenya (2017-2030)
Figure 86: Total Preterm births Based on Gestation Weeks in Kenya (2017-2030)
Figure 87: Total cases of Bronchopulmonary Dysplasia (BPD) in Kenya (2017-2030)
Figure 88: Total incident cases of BPD based on Gestation Period in Kenya (2017-2030)
Figure 89: Total incident cases of BPD based on Birth Weight in Kenya (2017-2030)
Figure 90: Severity of specific cases of BPD in Kenya (2017-2030)
Figure 91: Total Preterm births in Nigeria (2017-2030)
Figure 92: Total Preterm births Based on Gestation Weeks in Nigeria (2017-2030)
Figure 93: Total cases of Bronchopulmonary Dysplasia (BPD) in Nigeria (2017-2030)
Figure 94: Total incident cases of BPD based on Gestation Period in Nigeria (2017-2030)
Figure 95: Total incident cases of BPD based on Birth Weight in Nigeria (2017-2030)
Figure 96: Severity of specific cases of BPD in Nigeria (2017-2030)
Figure 97: Total Preterm births in Norway (2017-2030)
Figure 98: Total Preterm births Based on Gestation Weeks in Norway (2017-2030)
Figure 99: Total cases of Bronchopulmonary Dysplasia (BPD) in Norway (2017-2030)
Figure 100: Total incident cases of BPD based on Gestation Period in Norway (2017-2030)
Figure 101: Total incident cases of BPD based on Birth Weight in Norway (2017-2030)
Figure 102: Severity of specific cases of BPD in Norway (2017-2030)
Figure 103: Total Preterm births in Netherland (2017-2030)
Figure 104: Total Preterm births Based on Gestation Weeks in Netherland (2017-2030)
Figure 105: Total cases of Bronchopulmonary Dysplasia (BPD) in the Netherland (2017-2030)
Figure 106: Total incident cases of BPD based on Gestation Period in Netherland (2017-2030)
Figure 107: Total incident cases of BPD based on Birth Weight in the Netherland (2017-2030)
Figure 108: Severity of specific cases of BPD in the Netherland (2017-2030)
Figure 109: Total Preterm births in South Korea (2017-2030)
Figure 110: Total Preterm births Based on Gestation in South Korea (2017-2030)
Figure 111: Total cases of Bronchopulmonary Dysplasia (BPD) in South Korea (2017-2030)
Figure 112: Total incident cases of BPD based on Gestation Period in South Korea (2017-2030)
Figure 113: Total incident cases of BPD based on Birth Weight in South Korea (2017-2030)
Figure 114: Severity of specific cases of BPD in South Korea (2017-2030)
Figure 115: Total Preterm births in Sweden (2017-2030)
Figure 116: Total Preterm births in Sweden (2017-2030)
Figure 117: Total cases of Bronchopulmonary Dysplasia (BPD) in Sweden (2017-2030)
Figure 118: Total incident cases of BPD based on Gestation Period in Sweden (2017-2030)
Figure 119: Total incident cases of BPD based on Birth Weight in Sweden (2017-2030)
Figure 120: Severity of specific cases of BPD in Sweden (2017-2030)
Figure 121: Algorithm for BPD
Figure 122: Potential non-ventilator-dependent strategies to prevent or ameliorate BPD
Figure 123: Unmet Needs
Figure 124: Market Drivers
Figure 125: Market Barriers
Note: Product cover images may vary from those shown
Adroll
adroll